TITANBIO.BO BSE
Titan Biotech Limited
1W: -1.4%
1M: -0.9%
3M: +0.6%
YTD: +89.6%
1Y: -11.0%
3Y: +18.6%
5Y: +17.1%
₹383.00 ($3.98)
-8.50 (-2.17%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$295M
+46.6% ▲
5Y CAGR: +9.1%
Capital Expenditures
$93M
+1.4% ▲
5Y CAGR: +13.9%
Free Cash Flow
$202M
+89.1% ▲
5Y CAGR: +7.3%
Dividends Paid
$17M
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$37M
-261.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $290M | $281M | $249M | $215M | $299M |
| Depreciation & Amort. | $25M | $26M | $33M | $42M | $49M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$33M | -$30M | -$73M | -$35M | -$64M |
| Other Non-Cash Items | -$61M | -$66M | $2M | -$20M | $11M |
| Operating Cash Flow | $220M | $212M | $211M | $201M | $295M |
| — Investing Activities — | |||||
| Capital Expenditures | -$188M | -$132M | -$197M | -$94M | -$93M |
| Acquisitions (Net) | $0 | $0 | $110M | $0 | $43K |
| Investment Purchases | -$28M | -$76M | -$116M | -$13M | -$252M |
| Investment Sales | $0 | $0 | $0 | $150K | $348K |
| Other Investing | $51M | $0 | $0 | $8M | $160K |
| Investing Cash Flow | -$164M | -$207M | -$203M | -$99M | -$344M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$17M | -$5M | $2M | -$51M | $29M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$12M | -$12M | -$15M | -$17M | -$17M |
| Other Financing | -$68M | -$6M | -$16M | -$12M | $0 |
| Financing Cash Flow | -$41M | -$24M | -$29M | -$80M | $13M |
| Net Change in Cash | $15M | -$20M | -$20M | $23M | -$37M |
| Cash End of Period | $68M | $49M | $28M | $51M | $19M |
| Free Cash Flow | $84M | $84M | $15M | $107M | $202M |